Retatrutide: What You Need to Know

What It Is

Retatrutide is a new, experimental weight-loss medication that is currently being tested in clinical trials. Think of it as a next-generation weight-loss drug. It’s a once-weekly injection that works by targeting three different hormones in your body that control appetite, blood sugar, and how your body burns fat. This is what makes it a “triple-agonist.” It’s still in development, which means it’s not yet available at your local pharmacy.

Main Benefits

The early results from studies are pretty exciting. Here are some of the main potential benefits:

How It’s Typically Used

Retatrutide is given as a once-a-week shot, which you can do at home. Doctors usually start with a low dose and slowly increase it over time. This “low and slow” approach helps your body get used to the medication and reduces the chances of side effects.

Potential Downsides

Like any medication, Retatrutide has potential downsides. The most common ones are:

Who Might Consider This?

Retatrutide could be a good option for a few groups of people, once it’s approved:

Retatrutide vs. Tirzepatide

You might have heard of other new weight-loss drugs like Tirzepatide (sold as Mounjaro and Zepbound). Here’s a quick comparison:

Feature Retatrutide Tirzepatide
How it Works Triple-agonist (targets 3 hormones) Dual-agonist (targets 2 hormones)
Approval Status Not yet FDA-approved FDA-approved
Weight Loss Slightly higher average weight loss in studies so far Very effective, with significant weight loss

Compound Details

Detail Information
CAS Number 2381089-83-2
Molecular Formula C228H350N48O66
Sequence Tyr-Aib-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-αMeLeu-Leu-Asp-Lys-Lys(PEG2-γ-Glu-Eicosanedioic acid)-Ala-Gln-Aib-Ala-Phe-Ile-Glu-Tyr-Leu-Leu-Glu-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2
PubChem CID Not Available